Bayer has completed a year-long evaluation of NRGene's GenoMAGICTM data analytics platform, and expressed satisfaction with its ability to support the German company's genomics-based molecular breeding pipeline. “The world food demand is constantly on the rise, and life sciences companies like Bayer play a major role in our future food security,” said Dr. Gil Ronen, CEO of NRGene. Cloud-based GenoMAGICTM expands Bayer's ability to discover traits and to enhance genomes. The company is also working on integrating genomic information into other applications such as predictive analytics, machine learning and artificial intelligence. NRGene signed a licensing agreement with Monsanto prior to its acquisition by Bayer earlier this year.
Bayer has completed a year-long evaluation of NRGene's GenoMAGICTM data analytics platform, and expressed satisfaction with its ability to support the German company's genomics-based molecular breeding pipeline. Cloud-based GenoMAGICTM expands Bayer's ability to discover traits and to enhance genomes. The company is also working on integrating genomic information into other applications such as predictive analytics, machine learning and artificial intelligence. NRGene signed a licensing agreement with Monsanto prior to its acquisition by Bayer earlier this year.